Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Gman620


V.TLT

FDA focused?

I hope that the people at the FDA are not distracted by shredding documents...

11 hours ago

V.TLT

RE:RE:Potential US election impact on the FDA?

Unless a Theralase vaccine is proven by data to do more harm than good, RFK...

November 7, 2024

V.TLT

RE:New Paper by Dr. McFarland

Summarized by Chatgpt: Researchers created and studied five new iridium...

October 25, 2024

V.TLT

No Money = No leverage

If I'm a big pharma, I see a desperate company that is running out of...

September 3, 2024

V.TLT

Exciting News.... coming

No worries, it's not like funds are running low and things need to happen...

August 8, 2024

V.TLT

37 more trial subjects

TLT hired someone specifically to get those 37 trail subjects to make the...

April 23, 2024

V.TLT

RE:RE:RE:RE:Quote from Keytruda.com

Well, just following the money is an indicator. They are a lot farther along...

January 25, 2024

V.TLT

RE:RE:Quote from Keytruda.com

They  have a standalone trial/treatment and one with Keytruda. There is...

January 25, 2024

V.TLT

RE:RE:RE:RE:RE:RE:CG Oncology phase 3 results impossible for TLT to beat?

Why should TLT get BTD with this out there?  Having lots of treatments...

January 25, 2024

V.TLT

RE:RE:Incremental cost per study subject?

Right. Thanks. Not a great motivator to enrollment, but if you can fight the...

January 22, 2024

V.TLT

Incremental cost per study subject?

Does anyone have a sense what the incremental cost per study subject is to...

January 22, 2024

V.TLT

RE:RE:RE:RE:RE:RE:Dr. Ashish Kamat Interview - BOND-003 Study Results

Seems like they got a good sized study population pulled together pretty...

January 9, 2024

V.TLT

Green Swimlanes

From the video, It sounded like the FDA is requiring results from100 trial...

January 8, 2024

V.TLT

APPROVAL LAG

SUBMIT BTD---MONTH---MONEY?---MONTH---MONEY?---MONTH--MONEY?---MONTH...

December 15, 2023

V.TLT

RE:QUILT-3.032 Trial - BCG & N-803 for BCG-Unresponsive NMIBC

What a nightmare.

November 22, 2023

V.TLT

RE:RE:RE:RE:RE:RE:share activity

What is clear to me is that if they don't get a partner soon they will...

August 18, 2023

V.TLT

Hardware Requirement impact on FDA approval

Does requiring a piece of hardware (laser) for the treatment impact the...

May 18, 2023

V.TLT

3 (or more) treatments

Would a third treatment add significant testing burden (and cost)  to...

May 13, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:I don't see a mystery

I've stopped worrying about competitors overall. Usually I don't try...

April 18, 2023

V.TLT

RE:RE:RE:RE:RE:RE:I don't see a mystery

I don't want to argue against TLT. The discussion was about  all...

April 18, 2023

1 2 3 4 5 6 7 8 9 10 11 12 13 Next

Featured Company